Huge accumulation going on.
Trading at attractive valuations.
Good product mix.
Remdesivir API development. (If it commercialised then it can become a game changer for short term)
Past performance is so good
Disc: Invested
All above points are valid but recent movement is less stock linked it’s more like - Agar bakkion ko circuit lagg raha hai to isme kya kami hai 
Investment is not only about short term gains. If you hold a good growth stock it will deliver in long term.
In last quarter, plant shutdown for several weeks hence the price remained in range.
Stock market always looks in to the future and definitely it’s prospects are very good as they are more concentrated in antiviral drugs.
In lab stage they have Remdesivir API, if it is commercialised…
Micro cap investing involves huge risk and not suits for all types investors…
Disc:Invested.
Big move on the cards???
In last quarter plant shunt down made the stock to be in a consolidated phase but now all set to sky rocket for this micro cap stock.
Today hit the 20% upper circuit.
I find this to be true, cuz going by all the possible products and also the ones under-development mentioned on their website, these products are mostly used in generics and so they all are base APIs or commodities. Guess the run might be due to their Remedisivir API from the Lab.
Today Everest organics ended with 20% upper circuit.
Still it is a micro cap stock and they are concentrating on antiviral drugs and the opportunity size is very robust.
A Rs.300 cr company with USFDA approved lab, manufactured and commercialized first Oseltamivir, then Remdesivir and now anti-fungal for Black Fungus. I just can’t imagine.
D: Invested recently
Everest Organics Limited today announced the successful
development of an anti-fungal API “Posaconazole” meant to treat black fungus patients, at the lab scale in the existing R & D facility of Everest Organics Limited.
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients popularly known as Black Fungus in post Covid complications.
It's BIG BANG news.
Micro cap investing involves huge risk. Some companies may become 10× to 100× and some might disappear from the street.
It’s all about quality.
How to find quality???
There are known theories to find quality like observe cash flows, management quality etc.,
We may get some doubts on some companies whether they are existing or not???
This type of doubts are very common for micro caps.
With thanks
Be and Make
Considering plant shutdown for several weeks they managed with good top line but they failed to give better bottom line.
If we consider the YoY comparision still looks very promising.
Company commercialised Remdesvir is good sign and they were produced several fungal and viral related gives promising outlook for the company.
Conclusion:
Hold to observe few quarters
With thanks
Be and make
Another announcement from EOL:
At lab level, they are developing new products and some of them were turned in to commercial level also but in numbers they were unable to deliver.
Remdesivir is a example for it. EOL commercialised it but despite having huge demand they were unable to deliver in numbers.
Several times mailed to EOL CS but there was no reply.
Earlie EOL had pollution issues and resulted in to plant shutdowns.
Based on the above events, EOL need to come up with a clear vision to clarify the investors doubts till then it’s position only to be in a watchlist.
Dis: No holdings
What about keeping this stock for long term?
(not a trader, only long term investing)
Dear Nanda- It’s a micro cap stock hence you must know the risks involved in it.
Management not giving any guidance or response to investors issues.
If they come out with good intentions then things might be other way.
So far we can not say how the things will pan out!
You can hold the stock as you are aiming for long term.
With thanks
Be and Make
Downgrade by Credit rating agency. Highlighted statement from CRA poses significant risk to investors. This is a red flag.
Auditor qualification below
http://bcrisp.in///BLRHTML/HTMLDocument/ViewRatingRationaleINC?id=40903
The overstatement which auditors qualified is just around 1.12 crores and is not material enough. This may sometimes happen due to the grey areas of revenue recognition which Finance departments of many reputed companies too can be prone to error. Coming to the ratings downgrade, is Brickwork Ratings the only rating agency? It does happen that companies can be reached out to by multiple rating agencies and the company may be inclined to work with only 1 or 2 rating agencies, and hence non-cooperation with other agencies
@sreered. As a ex minority shareholder, I have just highlighted my concern.
Disclosure: No position currently.
Hello all. Does anyone have any idea about where this company is headed? After the sudden demise of the founder, there is no clarity on the strategic direction. The stock is down 50% from its highs. While a microcap with low liquidity can move up on one small good news, the reverse is also true. Any inputs will be helpful.
Disclosure: Invested.
